Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...

Fresenius SE raised close to €1.1 billion ($1.2 billion) in a sale of shares in Fresenius Medical Care AG as well as ...

The healthcare company said it had sold 3.6% of Fresenius Medical Care’s share capital and that it would use the proceeds to ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, released its 2024 Annual Report including its Sustainability Statement. By ...

Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, ...

German healthcare group Fresenius reported fourth-quarter earnings above market expectations on Wednesday, driven by a strong performance at its hospital drug unit Kabi.

Gain insight on Fresenius, Clarity and more in the latest Market Talks covering ...

Kepler Capital analyst Oliver Reinberg maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) on March 13 and set a ...

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) on March ...

Fresenius, the German health care group, sold 3.6% of the shares in kidney dialysis provider Fresenius Medical Care on Monday ...